Method of treatment and / or prevention of oxidative stress, stress and / or vascular endothelial dysfunction in diabetic patients or in patients with Type 1 diabetes such as, Latent autoimmune diabetes in adults (LADA) and type 2 diabetes, comprising administering linagliptin; Compound Lin Agliptina, dpp-4 inhibitor.

摘要

The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as well as to the use of such DPP-4 inhibitors in treatment and/or prevention of diabetic or non-diabetic patients, including patient groups at risk of cardiovascular and/or renal disease.